KLOX Technologies reports on final results from its clinical study on LumiHeal™ for the treatment of chronic wounds
03 mai 2017 10h30 HE
|
Klox Technologies, Inc.
LAVAL, Quebec, May 03, 2017 (GLOBE NEWSWIRE) -- Today, the final results on KLOX Technologies’ (Klox) EUREKA study, which evaluated LumiHeal in the treatment of hard-to-heal, non-responsive, chronic...
Preliminary results for Phovia™ in the treatment of Canine Chronic Otitis to be presented at ECVS scientific meeting
27 mars 2017 02h30 HE
|
Klox Technologies, Inc.
DUBLIN, Ireland, March 27, 2017 (GLOBE NEWSWIRE) -- Klox Technologies Limited, a subsidiary of Klox Technologies Inc. (‘Klox’) has announced that the European College of Veterinary Surgeons (‘ECVS’)...
KLOX Technologies dévoile les résultats intérimaires d’études cliniques en cours sur l’utilisation de LumiHealMD pour le traitement de plaies chroniques et de la cicatrisation post-chirurgicale
28 sept. 2016 06h00 HE
|
Klox Technologies, Inc.
LAVAL, Quebec, Sept. 28, 2016 (GLOBE NEWSWIRE) -- Aujourd’hui, les résultats cliniques intérimaires sur l’utilisation de LumiHealMD de KLOX Technologies (Klox) pour le traitement des plaies...
KLOX Technologies reports on its interim results from its ongoing clinical studies on LumiHeal™ for the treatment of chronic wounds and postsurgical scarring
28 sept. 2016 06h00 HE
|
Klox Technologies, Inc.
LAVAL, Quebec, Sept. 28, 2016 (GLOBE NEWSWIRE) -- Today, clinical interim results on KLOX Technologies (Klox) LumiHealTM for the treatment of hard-to-heal non-responsive chronic wounds and...